JoNel Aleccia/AP

STAT+ | U.S. health spending rose sharply in 2025, thanks to GLP-1 use and more care

Health care spending rose 7.3% in 2025, to $5.7 trillion, fueled by an 11% rise in prescription drugs. Health care now accounts for 18.4% of the economy.

By Bob Herman

STAT+ | AI wades into a vexing medical mystery: What causes sudden cardiac death?

A new study published in Nature uses artificial intelligence to identify people at high risk for sudden cardiac death, and pinpoints a possible reason.

By Casey Ross

STAT+ | What an abandoned heart failure trial says about ‘breakthrough’ devices that don’t reach patients

Most FDA breakthrough devices never make it to market. Research published after LivaNova's VITARIA trial ended early shows the benefit of more transparency.

By Katie Palmer

Sandy Huffaker/Getty Images/STAT

Opinion: New human embryo editing advances require tough conversations on ethical boundaries

Some notable choices and complexities related to geneticist Dieter Egli’s new embryo-editing study carry ethical baggage.

By Paul Knoepfler

Clinical trial set to test two drugs for fast-growing Ebola outbreak

World Health Organization to launch clinical trials next week of two Ebola treatments, Gilead's remdesivir and MappBio's monoclonal antibody MBP–134.

By Helen Branswell

STAT+ | Eli Lilly dives into hair loss treatments with investment in AI startup Absci

The deal is centered around Absci's early-stage hair loss drug ABS-201, which it designed using artificial intelligence tools. 

By Allison DeAngelis

Courtesy Whoop

STAT+ | FDA drops enforcement against Whoop after it tweaks blood pressure feature

The FDA told wearable maker Whoop that the agency would not take further enforcement action over the company's controversial blood pressure feature.

By Mario Aguilar

STAT+ | Wagering on FDA changes, Regenxbio will submit Duchenne gene therapy for approval

The company had previously said it would hold off on filing the rare disease treatment to the FDA, with the agency wanting additional data.

By Jason Mast